FEATURED

Nivolumab for Advanced RCC: Cost, Value

As treatment options increase, patient-reported outcomes and cost-effective analyses will play a key role in determining how drugs are sequenced in clinical practice.

Fact Sheet: Breast Cancer During Pregnancy

The authors of a recent review developed 6 crucial care points for treating pregnant patients with breast cancer.

Lung Cancer Immunotherapy in Elderly Patients

Targeted and immunotherapies appear to be opening a new frontier in the management of elderly patients.

Pediatric CML: Targeting Treatment

Researchers argue that children with CML should receive different treatments than adults, which may mitigate long-term side effects.

Drug Showcase: ERIVEDGE (vismodegib)

Indicated for basal cell carcinoma.

Managing Gastrinomas: Evaluating Treatment Options

Gastrinomas, rare endocrine tumors, can be treated in multiple ways, regardless of whether the tumor is resectable.

Meta-analysis Outlines Treatments for MM

A meta-analysis found that the "best treatment" for prolonging PFS in R/R MM was daratumumab, lenalidomide, and dexamethasone.

SGO 2017 Coverage

Complete coverage of the 2017 Society of Gynecologic Oncology meeting in Maryland.

Non-invasive Biomarkers for Prostate Cancer

Can liquid biopsy and molecular imaging biomarkers help inform more precise management of patients with metastatic prostate cancer?

Immunotherapy in the Twentieth Century

Dr Clifford Pukel, a board certified medical oncologist and CEO of the CVCI foundation, discusses some important moments in the history of immunotherapy.

For the treatment of metastatic non-small

Biomarker testing for epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) substitution mutations is important when considering a first-line therapy

New Video Series: Classical Hodgkin Lymphoma

Steven M. Ansell, MD, PhD, of the Mayo Clinic in Rochester, Minnesota

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Featured Resource

A multidisciplinary team (MDT) approach is necessary in treating metastatic breast cancer in order to provide optimal care. This article, published in JNCCN, reviews the findings of an educational needs assessment of the multidisciplinary breast cancer management team.


Latest Features

Nivolumab for Advanced Renal Cell Carcinoma: Cost and Value

Nivolumab for Advanced Renal Cell Carcinoma: Cost and Value

As treatment options increase, patient-reported outcomes and cost-effective analyses will play a key role in determining how drugs are sequenced in clinical practice.

Lung Cancer Immunotherapy in Elderly Patients: Cause for Optimism?

Lung Cancer Immunotherapy in Elderly Patients: Cause for Optimism?

Targeted and immunotherapies appear to be opening a new frontier in the management of elderly patients.

Corrective Action Plans May Accompany HIPAA Fines

Corrective Action Plans May Accompany HIPAA Fines

In serious breach cases, the HHS Office for Civil Rights may impose CAPs to prevent breaches from recurring.

Pediatric Chronic Myeloid Leukemia: Targeting Treatment

Pediatric Chronic Myeloid Leukemia: Targeting Treatment

Researchers argue that children with CML should receive different treatments than adults, which may mitigate long-term side effects.

Managing Gastrinomas: Evaluating Treatment Options

Managing Gastrinomas: Evaluating Treatment Options

Gastrinomas, rare endocrine tumors, can be treated in multiple ways, regardless of whether the tumor is resectable.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters